- GSK Stockmann + Kollegen

MUNICH
Deal news
Karl-Scharnagl-Ring 8
80539 München
Tel +49 89 28 81 74-0
Fax +49 89 28 81 74-44
[email protected]
Munich, 8 March 2011
GSK Stockmann + Kollegen advises the Williams Formula
One Team in IPO at Frankfurt Stock Exchange
Williams Grand Prix Holdings PLC broke new ground on 2 March 2011 when it became the first Formula One team to list on a stock exchange. GSK Stockmann +
Kollegen acted as advisors to Williams in preparation for their public offering on the
Entry Standard of the Frankfurt Stock Exchange, the largest IPO listing on the Entry
Standard to date.
The IPO saw Williams place around 24% of existing share capital, with a purchase
price of EUR 25.00 per share. Market capitalisation valued the company at
EUR 250 million.
Founded in 1977 by Frank Williams and Patrick Head, Williams has since become
one of the most successful teams in Formula One history. In total, the team has won
16 FIA Formula One World Championship titles (9 Constructors' Championships
and 7 Drivers' Championships).
GSK Stockmann + Kollegen advised Williams in the drafting of the securities prospectus as well as in all legal aspects relating to the listing on the Entry Standard.
The approval of the securities prospectus by the British supervisory authority Financial Services Authority (FSA) and in other aspects of English law, GSK Stockmann +
Kollegen worked together with English law firm Manches LLP in Oxford. The issuer’s
banks, Swiss Bank am Bellevue AG and German Baader Bank AG, were advised by
Nabarro LLP, the English partner law firm of GSK Stockmann + Kollegen.
“We are delighted that we could support Williams in this important transaction and
that we were part of the first ever IPO of a Formula One racing team”, says Hendrik
Riedel, the partner in charge at GSK Stockmann + Kollegen. With that, Hendrik
Riedel has advised both motorsport companies – Williams and HWA AG – in their
IPO’s at Entry Standard in Frankfurt.
Seite 1 von 2
Legal advisor to Williams Grand Prix Holdings PLC:
GSK Stockmann + Kollegen: Hendrik Riedel, LL.M. (project management, capital
markets law), Dr. Tilman Durchlaub (capital markets law, both corporate, Munich),
Dr. Dirk Koch (tax, Stuttgart)
Contact:
GSK STOCKMANN + KOLLEGEN
Hendrik Riedel, LL.M.
Karl-Scharnagl-Ring 8, 80539 München
Tel.: +49 89 28 81 74-0
Fax: +49 89 28 81 74-44
E-Mail: [email protected]
GSK Stockmann + Kollegen is one of Germany’s leading independent law firms. We
offer tailored legal advice in our main practice areas of corporate and real estate as
well as in our specialist areas banking and public law. GSK was founded in 1997 by
lawyers from renowned business law firms. Today, more than 130 attorneys are at
our clients’ disposal at our offices in Berlin, Duesseldorf, Frankfurt, Hamburg, Heidelberg, Munich, Stuttgart, Brussels and in Singapore.
For further information, please visit: www.gsk.de
In cross-border transactions, GSK is closely cooperating with a selected circle of
reputable law firms encompassing the most significant European jurisdictions.
These law firms are Nabarro LLP (UK), August & Debouzy (France) and Nunziante
Magrone (Italy). This exclusive alliance now has more than 830 lawyers in Europe’s
most important financial and economic centres based in 16 offices, covering also the
European metropolis Brussels as well as North Africa.
For further information, please visit: www.ourwayofdoinginternationalbusiness.com
GSK. The difference.
Seite 2 von 2